WINDSOR, Ontario--(BUSINESS WIRE)--Valeant Pharmaceuticals International Inc. (NYSE: VRX; TSX: VRX), is being investigated by Sutts, Strosberg LLP, a law firm that represents investors in securities class actions.
The firm is investigating the company in the wake of a report by Citron Research claiming that Valeant Pharmaceuticals uses a network of phantom captive pharmacies to artificially boost Valeant’s revenues through channel stuffing. On the day of the report, the company’s shares were trading more than 25% below the previous day’s close.
The firm would like to speak with shareholders of Valeant Pharmaceuticals. Shareholders who wish to discuss the matter should contact Jay Strosberg at (519) 561-6285 or by email at firstname.lastname@example.org.
Sutts, Strosberg LLP is a leading class action law firm that has recovered over $1.5 billion for its clients. For more information about the law firm, please visit the Sutts, Strosberg LLP website at www.strosbergco.com.